{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T03:10:11Z","timestamp":1731381011640,"version":"3.28.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,11]]},"DOI":"10.7759\/cureus.73483","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T02:34:58Z","timestamp":1731378898000},"source":"Crossref","is-referenced-by-count":0,"title":["Mixed Ovarian Carcinoma Comprising Clear Cell Carcinoma and Endometrioid Carcinoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Jason D","family":"Susanto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praisela S","family":"Hendrieta Nelwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fajar L","family":"Gultom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Batara I","family":"Sirait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwan K","family":"Effendi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre LA","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE, et al.. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018, 68:284-96. 10.3322\/caac.21456","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-021-00804-1","article-title":"Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study","volume":"14","author":"Zhou L","year":"2021","unstructured":"Zhou L, Yao L, Dai L, et al.. Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study. J Ovarian Res. 2021, 14:63. 10.1186\/s13048-021-00804-1","journal-title":"J Ovarian Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010881","article-title":"Clear cell carcinoma of the ovary: clinicopathologic features and outcomes in a Chinese cohort","volume":"97","author":"Tang H","year":"2018","unstructured":"Tang H, Liu Y, Wang X, Guan L, Chen W, Jiang H, Lu Y. Clear cell carcinoma of the ovary: clinicopathologic features and outcomes in a Chinese cohort. Medicine (Baltimore). 2018, 97:e10881. 10.1097\/MD.0000000000010881","journal-title":"Medicine (Baltimore)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000536","article-title":"Molecular analysis of mixed endometrial carcinomas shows clonality in most cases","volume":"40","author":"K\u00f6bel M","year":"2016","unstructured":"K\u00f6bel M, Meng B, Hoang LN, et al.. Molecular analysis of mixed endometrial carcinomas shows clonality in most cases. Am J Surg Pathol. 2016, 40:166-80. 10.1097\/PAS.0000000000000536","journal-title":"Am J Surg Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/path.6006","article-title":"The proteome of clear cell ovarian carcinoma","volume":"258","author":"Ji JX","year":"2022","unstructured":"Ji JX, Cochrane DR, Negri GL, et al.. The proteome of clear cell ovarian carcinoma. J Pathol. 2022, 258:325-38. 10.1002\/path.6006","journal-title":"J Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/11795476231166623","article-title":"Advanced stage clear cell ovarian carcinoma mimicking uterine sarcoma without gross residual tumor during primary surgery: a case report","volume":"16","author":"Angelina YA","year":"2023","unstructured":"Angelina YA, Tjokroprawiro BA. Advanced stage clear cell ovarian carcinoma mimicking uterine sarcoma without gross residual tumor during primary surgery: a case report. Clin Med Insights Case Rep. 2023, 16:11795476231166623. 10.1177\/11795476231166623","journal-title":"Clin Med Insights Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2023.08.005","article-title":"Mixed clear cell\/endometrioid and clear cell\/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology\/Gynecologic Oncology Group (GOG-210) study of 311 women","volume":"177","author":"Hagemann IS","year":"2023","unstructured":"Hagemann IS, Deng W, Zaino RJ, et al.. Mixed clear cell\/endometrioid and clear cell\/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology\/Gynecologic Oncology Group (GOG-210) study of 311 women. Gynecol Oncol. 2023, 177:38-45. 10.1016\/j.ygyno.2023.08.005","journal-title":"Gynecol Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000001050","article-title":"Clear cell carcinoma of the endometrium: evaluation of prognostic parameters in a multi-institutional cohort of 165 cases","volume":"27","author":"Abdulfatah E","year":"2017","unstructured":"Abdulfatah E, Sakr S, Thomas S, et al.. Clear cell carcinoma of the endometrium: evaluation of prognostic parameters in a multi-institutional cohort of 165 cases. Int J Gynecol Cancer. 2017, 27:1714-21. 10.1097\/IGC.0000000000001050","journal-title":"Int J Gynecol Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5114\/pm.2023.128661","article-title":"Epidemiology and risk factors for ovarian cancer","volume":"22","author":"Ali AT","year":"2023","unstructured":"Ali AT, Al-Ani O, Al-Ani F. Epidemiology and risk factors for ovarian cancer. Prz Menopauzalny. 2023, 22:93-104. 10.5114\/pm.2023.128661","journal-title":"Prz Menopauzalny"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2019.03.243","article-title":"Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study","volume":"153","author":"Machida H","year":"2019","unstructured":"Machida H, Matsuo K, Yamagami W, et al.. Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study. Gynecol Oncol. 2019, 153:589-96. 10.1016\/j.ygyno.2019.03.243","journal-title":"Gynecol Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.5113","article-title":"Risk of malignant ovarian cancer based on ultrasonography findings in a large unselected population","volume":"179","author":"Smith-Bindman R","year":"2019","unstructured":"Smith-Bindman R, Poder L, Johnson E, Miglioretti DL. Risk of malignant ovarian cancer based on ultrasonography findings in a large unselected population. JAMA Intern Med. 2019, 179:71-7. 10.1001\/jamainternmed.2018.5113","journal-title":"JAMA Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33012","article-title":"Infertility and ovarian cancer risk: evidence from nine prospective cohort studies","volume":"147","author":"Jiang YT","year":"2020","unstructured":"Jiang YT, Gong TT, Zhang JY, Li XQ, Gao S, Zhao YH, Wu QJ. Infertility and ovarian cancer risk: evidence from nine prospective cohort studies. Int J Cancer. 2020, 147:2121-30. 10.1002\/ijc.33012","journal-title":"Int J Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.30699\/ijp.2020.106598.2222","article-title":"Napsin-A expression, a reliable immunohistochemical marker for diagnosis of ovarian and endometrial clear cell carcinomas","volume":"15","author":"Nili F","year":"2020","unstructured":"Nili F, Tavakoli M, Izadi Mood N, Saffar H, Sarmadi S. Napsin-A expression, a reliable immunohistochemical marker for diagnosis of ovarian and endometrial clear cell carcinomas. Iran J Pathol. 2020, 15:81-5. 10.30699\/ijp.2020.106598.2222","journal-title":"Iran J Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12784","article-title":"Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma","volume":"126","author":"Rekhi B","year":"2018","unstructured":"Rekhi B, Deodhar KK, Menon S, et al.. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma. APMIS. 2018, 126:45-55. 10.1111\/apm.12784","journal-title":"APMIS"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-015-0242-z","article-title":"Immunoexpression of napsin A in renal neoplasms","volume":"10","author":"Zhu B","year":"2015","unstructured":"Zhu B, Rohan SM, Lin X. Immunoexpression of napsin A in renal neoplasms. Diagn Pathol. 2015, 10:4. 10.1186\/s13000-015-0242-z","journal-title":"Diagn Pathol"},{"key":"ref16","unstructured":"Pathology outlines- endometrioid carcinoma. (2023). Accessed. March 18, 2024: https:\/\/www.pathologyoutlines.com\/topic\/ovarytumorendometrioidcarcinoma.html."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy071","article-title":"Invasive epithelial ovarian cancer survival by histotype and disease stage","volume":"111","author":"Peres LC","year":"2019","unstructured":"Peres LC, Cushing-Haugen KL, K\u00f6bel M, et al.. Invasive epithelial ovarian cancer survival by histotype and disease stage. J Natl Cancer Inst. 2019, 111:60-8. 10.1093\/jnci\/djy071","journal-title":"J Natl Cancer Inst"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0158","article-title":"Sexual steroid hormone receptors profiles of ovarian carcinoma in Mexican women","volume":"7","author":"G\u00f3mora MJ","year":"2018","unstructured":"G\u00f3mora MJ, Morales-V\u00e1squez F, Pedernera E, et al.. Sexual steroid hormone receptors profiles of ovarian carcinoma in Mexican women. Endocr Connect. 2018, 7:1006-12. 10.1530\/EC-18-0158","journal-title":"Endocr Connect"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000274","article-title":"An immunohistochemical algorithm for ovarian carcinoma typing","volume":"35","author":"K\u00f6bel M","year":"2016","unstructured":"K\u00f6bel M, Rahimi K, Rambau PF, et al.. An immunohistochemical algorithm for ovarian carcinoma typing. Int J Gynecol Pathol. 2016, 35:430-41. 10.1097\/PGP.0000000000000274","journal-title":"Int J Gynecol Pathol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2018.29.e18","article-title":"Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis","volume":"29","author":"Paik ES","year":"2018","unstructured":"Paik ES, Kim TJ, Choi CH, Kim BG, Bae DS, Lee JW. Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis. J Gynecol Oncol. 2018, 29:e18. 10.3802\/jgo.2018.29.e18","journal-title":"J Gynecol Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/259896-mixed-ovarian-carcinoma-comprising-clear-cell-carcinoma-and-endometrioid-carcinoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T02:35:00Z","timestamp":1731378900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/259896-mixed-ovarian-carcinoma-comprising-clear-cell-carcinoma-and-endometrioid-carcinoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.73483","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,11]]}}}